tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RVPH Stock Latest News

Reviva Pharmaceuticals initiated with a Buy at Chardan
The FlyReviva Pharmaceuticals initiated with a Buy at Chardan
4d ago
RVPH
Reviva Pharmaceuticals Amends Bylaws to Ease Quorum
PremiumCompany Announcements
Reviva Pharmaceuticals Amends Bylaws to Ease Quorum
6d ago
8K
RVPH
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
13d ago
HD
MU
Reviva Pharmaceuticals Announces Public Offering to Raise Funds
PremiumCompany Announcements
Reviva Pharmaceuticals Announces Public Offering to Raise Funds
13d ago
8K
RVPH
Why Is Reviva Pharmaceuticals Stock (RVPH) Down 40% Today?
PremiumMarket News
Why Is Reviva Pharmaceuticals Stock (RVPH) Down 40% Today?
14d ago
RVPH
Reviva Pharmaceuticals price target lowered to $2 from $3 at D. Boral Capital
PremiumThe FlyReviva Pharmaceuticals price target lowered to $2 from $3 at D. Boral Capital
14d ago
RVPH
Reviva Pharmaceuticals 27M share Spot Secondary priced at $0.33
Premium
The Fly
Reviva Pharmaceuticals 27M share Spot Secondary priced at $0.33
14d ago
RVPH
Reviva Pharmaceuticals announces common stock, warrants offering
Premium
The Fly
Reviva Pharmaceuticals announces common stock, warrants offering
14d ago
RVPH
Reviva Pharmaceuticals price target lowered to $7 from $14 at Benchmark
PremiumThe Fly
Reviva Pharmaceuticals price target lowered to $7 from $14 at Benchmark
18d ago
RVPH
Reviva Pharmaceuticals Advances Schizophrenia Treatment
PremiumCompany Announcements
Reviva Pharmaceuticals Advances Schizophrenia Treatment
2M ago
RVPH
Reviva Pharmaceuticals price target lowered to $2 from $5 at Maxim
PremiumThe Fly
Reviva Pharmaceuticals price target lowered to $2 from $5 at Maxim
2M ago
RVPH
Reviva Pharmaceuticals price target lowered to $3 from $7 at Roth Capital
PremiumThe Fly
Reviva Pharmaceuticals price target lowered to $3 from $7 at Roth Capital
2M ago
RVPH
Reviva Pharmaceuticals price target lowered to $3 from $7 at Roth Capital
PremiumThe FlyReviva Pharmaceuticals price target lowered to $3 from $7 at Roth Capital
2M ago
RVPH
Reviva Pharmaceuticals price target lowered to $2 from $5 at Maxim
Premium
The Fly
Reviva Pharmaceuticals price target lowered to $2 from $5 at Maxim
2M ago
RVPH
Reviva Pharmaceuticals reports Q2 EPS (12c) vs. (26c) last year
Premium
The Fly
Reviva Pharmaceuticals reports Q2 EPS (12c) vs. (26c) last year
2M ago
RVPH
Reviva Pharmaceuticals Announces Public Offering Agreement
PremiumCompany Announcements
Reviva Pharmaceuticals Announces Public Offering Agreement
3M ago
8K
RVPH
Reviva Pharmaceuticals prices 20M shares at 50c in public offering
PremiumThe Fly
Reviva Pharmaceuticals prices 20M shares at 50c in public offering
3M ago
RVPH
Reviva Pharmaceuticals announces common stock, warrants offering
PremiumThe Fly
Reviva Pharmaceuticals announces common stock, warrants offering
3M ago
RVPH
Reviva Pharmaceuticals Holdings: Positive Phase 3 Data and Favorable Safety Profile Support Buy Rating
PremiumRatings
Reviva Pharmaceuticals Holdings: Positive Phase 3 Data and Favorable Safety Profile Support Buy Rating
4M ago
RVPH
Reviva Pharmaceuticals Completes Phase 3 Study for Schizophrenia
PremiumCompany AnnouncementsReviva Pharmaceuticals Completes Phase 3 Study for Schizophrenia
4M ago
8K
RVPH
Reviva Pharmaceuticals announces full dataset for one-year Phase 3 RECOVER study
Premium
The Fly
Reviva Pharmaceuticals announces full dataset for one-year Phase 3 RECOVER study
4M ago
RVPH
Reviva Pharmaceuticals Launches $50M At-Market Offering
Premium
Company Announcements
Reviva Pharmaceuticals Launches $50M At-Market Offering
4M ago
8K
RVPH

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >